BEAM
Price
$28.14
Change
+$0.37 (+1.33%)
Updated
Dec 24 closing price
Capitalization
2.86B
68 days until earnings call
Intraday BUY SELL Signals
TSHA
Price
$5.91
Change
+$0.20 (+3.50%)
Updated
Dec 24 closing price
Capitalization
1.62B
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs TSHA

Header iconBEAM vs TSHA Comparison
Open Charts BEAM vs TSHABanner chart's image
Beam Therapeutics
Price$28.14
Change+$0.37 (+1.33%)
Volume$430.29K
Capitalization2.86B
Taysha Gene Therapies
Price$5.91
Change+$0.20 (+3.50%)
Volume$1.73M
Capitalization1.62B
BEAM vs TSHA Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. TSHA commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and TSHA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (BEAM: $28.14 vs. TSHA: $5.91)
Brand notoriety: BEAM and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 20% vs. TSHA: 46%
Market capitalization -- BEAM: $2.86B vs. TSHA: $1.62B
BEAM [@Biotechnology] is valued at $2.86B. TSHA’s [@Biotechnology] market capitalization is $1.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while TSHA’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 5 bearish.
  • TSHA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +9.92% price change this week, while TSHA (@Biotechnology) price change was +8.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

TSHA is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.86B) has a higher market cap than TSHA($1.62B). TSHA YTD gains are higher at: 241.618 vs. BEAM (13.468). TSHA has higher annual earnings (EBITDA): -98.71M vs. BEAM (-434.55M). BEAM has more cash in the bank: 1.08B vs. TSHA (297M). TSHA has less debt than BEAM: TSHA (69M) vs BEAM (151M). BEAM has higher revenues than TSHA: BEAM (55.7M) vs TSHA (6.31M).
BEAMTSHABEAM / TSHA
Capitalization2.86B1.62B176%
EBITDA-434.55M-98.71M440%
Gain YTD13.468241.6186%
P/E RatioN/A2.70-
Revenue55.7M6.31M883%
Total Cash1.08B297M362%
Total Debt151M69M219%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMTSHA
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PYEQX25.610.13
+0.51%
Victory Pioneer Equity Income Y
RYAVX78.290.31
+0.40%
Rydex S&P MidCap 400 Pure Value H
HBLTX14.860.04
+0.27%
Hartford Balanced Income R5
SDGCX84.070.11
+0.13%
DWS Capital Growth C
IRFAX9.070.01
+0.11%
Cohen & Steers International Realty A

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+1.33%
CRSP - BEAM
72%
Closely correlated
+0.44%
RXRX - BEAM
61%
Loosely correlated
+0.92%
NTLA - BEAM
61%
Loosely correlated
+1.80%
PRME - BEAM
60%
Loosely correlated
-3.25%
AXON - BEAM
57%
Loosely correlated
+0.02%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with PCVX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+3.50%
PCVX - TSHA
51%
Loosely correlated
-0.33%
NGNE - TSHA
50%
Loosely correlated
-0.05%
RGNX - TSHA
47%
Loosely correlated
+0.77%
SLDB - TSHA
44%
Loosely correlated
N/A
BEAM - TSHA
44%
Loosely correlated
+1.33%
More